{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:34:58Z","timestamp":1754159698896,"version":"3.41.2"},"reference-count":92,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.path.2025.01.004","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T07:31:39Z","timestamp":1747899099000},"page":"597-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hematolymphoid Tumors of Bone"],"prefix":"10.1016","volume":"18","author":[{"given":"Megan J.","family":"Fitzpatrick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A.","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.path.2025.01.004_bib1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.path.2017.04.011","article-title":"Hematopoietic tumors primarily presenting in bone","volume":"10","author":"Cleven","year":"2017","journal-title":"Surg Pathol Clin"},{"issue":"1","key":"10.1016\/j.path.2025.01.004_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.semdp.2014.01.004","article-title":"Primary lymphoma of bone: a review","volume":"31","author":"Bhagavathi","year":"2014","journal-title":"Semin Diagn Pathol"},{"volume":"vol. 3","year":"2020","key":"10.1016\/j.path.2025.01.004_bib3"},{"issue":"10","key":"10.1016\/j.path.2025.01.004_bib4","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/PAS.0b013e3181b314ce","article-title":"Primary bone diffuse large B-cell lymphoma clinicopathologic study of 21 cases and review of literature","volume":"33","author":"Bhagavathi","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.01.004_bib5","first-page":"1","article-title":"Primary bone lymphoma: a case series and review of literature","volume":"2020","author":"Bindal","year":"2020","journal-title":"Case Rep Hematol"},{"issue":"2","key":"10.1016\/j.path.2025.01.004_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.xrrt.2023.12.008","article-title":"Delayed diagnosis of a primary diffuse large B-cell lymphoma of the humeral head, presenting as pathological fracture: a case report and review of the literature","volume":"4","author":"Panagopoulos","year":"2024","journal-title":"JSES Reviews, Reports, and Techniques"},{"issue":"12","key":"10.1016\/j.path.2025.01.004_bib7","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1002\/cncr.21930","article-title":"Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients","volume":"106","author":"Beal","year":"2006","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.path.2025.01.004_bib8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jcp.2008.063156","article-title":"Primary lymphoma of bone: extranodal lymphoma with favourable survival independent of germinal centre, post-germinal centre or indeterminate phenotype","volume":"62","author":"Heyning","year":"2009","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.path.2025.01.004_bib9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijrobp.2011.06.1976","article-title":"Early-stage primary bone lymphoma: a retrospective, multicenter Rare Cancer Network (RCN) study","volume":"83","author":"Cai","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.path.2025.01.004_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100440","article-title":"Follicular lymphoma presenting with symptomatic bone involvement: a clinicopathologic and molecular analysis of 16 cases","volume":"37","author":"Sarro","year":"2024","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.path.2025.01.004_bib11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/ajcp\/aqab067","article-title":"Unexpected primary extranodal marginal zone lymphoma of bone in amputation and arthroplasty specimens","volume":"156","author":"Diaz-Perez","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.path.2025.01.004_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.htct.2020.08.010","article-title":"Primary pediatric Burkitt\u2019s lymphoma of both femurs\u2014case report","volume":"44","author":"Viotto","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.path.2025.01.004_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.07.028","article-title":"Primary lymphoma of bone in the pediatric and young adult population","volume":"60","author":"Chisholm","year":"2017","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.path.2025.01.004_bib14","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1200\/JCO.2002.06.017","article-title":"Non-Hodgkin\u2019s lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children\u2019s Cancer Group report","volume":"20","author":"Lones","year":"2002","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.path.2025.01.004_bib15","article-title":"Primary non-hodgkin\u2019s lymphoma of bone in children","volume":"88","author":"Glotzbecker","year":"2006","journal-title":"J Bone Joint Surg Am"},{"issue":"8","key":"10.1016\/j.path.2025.01.004_bib16","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1007\/s11999-013-2991-x","article-title":"Malignant lymphoma of bone: a review of 119 patients tumor","volume":"471","author":"Demircay","year":"2013","journal-title":"Clin Orthop Relat Res"},{"issue":"5","key":"10.1016\/j.path.2025.01.004_bib17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1309\/CMPGPYTMFRM6RVQR","article-title":"Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene","volume":"129","author":"Lima","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.path.2025.01.004_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000000923","article-title":"Primary bone lymphoma exhibits a favorable prognosis and distinct gene expression signatures resembling diffuse large B-cell lymphoma derived from centrocytes in the germinal center","volume":"41","author":"Li","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2025.01.004_bib19","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/sj.leu.2401582","article-title":"Primary non-Hodgkin\u2019s lymphoma of bone: a clinicopathological investigation of 60 cases","volume":"13","author":"Heyning","year":"1999","journal-title":"Leukemia"},{"issue":"32","key":"10.1016\/j.path.2025.01.004_bib20","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1200\/JCO.2012.48.0467","article-title":"Impact of rituximab and radiotherapy on outcome of patients with aggressive B-cell lymphoma and skeletal involvement","volume":"31","author":"Held","year":"2013","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.path.2025.01.004_bib21","article-title":"Diffuse large B-cell lymphoma of bone an analysis of differentiation-associated antigens with clinical correlation","volume":"27","author":"De","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2025.01.004_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1634\/theoncologist.2013-0249","article-title":"Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study)","volume":"19","author":"Bruno","year":"2014","journal-title":"Oncol"},{"issue":"5","key":"10.1016\/j.path.2025.01.004_bib23","first-page":"1439","article-title":"Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study","volume":"109","author":"Rezazadeh","year":"2024","journal-title":"Haematologica"},{"year":"2024","series-title":"Haematolymphoid tumours","key":"10.1016\/j.path.2025.01.004_bib24"},{"issue":"7","key":"10.1016\/j.path.2025.01.004_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ajh.23201","article-title":"Trends and outcomes of modern staging of solitary plasmacytoma of bone","volume":"87","author":"Warsame","year":"2012","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.path.2025.01.004_bib26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/cam4.3533","article-title":"Survival trends and prognostic factors in patients with solitary plasmacytoma of bone: a population-based study","volume":"10","author":"Shen","year":"2021","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.path.2025.01.004_bib27","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00432-020-03452-y","article-title":"Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience","volume":"147","author":"Alghisi","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.path.2025.01.004_bib28","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.3324\/haematol.2022.282214","article-title":"Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma","volume":"108","author":"Ascione","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.path.2025.01.004_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2559.2004.01763.x","article-title":"Morphological variants of plasma cell tumours","author":"Banerjee","year":"2004","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.path.2025.01.004_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3960\/jslrt.18014","article-title":"The histopathology of myeloma in the bone marrow","volume":"58","author":"Fujino","year":"2018","journal-title":"J Clin Exp Hematop"},{"issue":"2","key":"10.1016\/j.path.2025.01.004_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrclinonc.2016.122","article-title":"Genomic complexity of multiple myeloma and its clinical implications","volume":"14","author":"Manier","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.path.2025.01.004_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11680-1","article-title":"Genomic landscape and chronological reconstruction of driver events in multiple myeloma","volume":"10","author":"Maura","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.path.2025.01.004_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1309\/AJCPUS3PRRT5ZXVS","article-title":"Clinical, immunophenotypic, and genetic characterization of small lymphocyte-like plasma cell myeloma: a potential mimic of mature B-cell lymphoma","volume":"133","author":"Heerema-McKenney","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.path.2025.01.004_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4274\/tjh.2017.0329","article-title":"Pleomorphic multinucleated plasma cells simulating megakaryocytes in an anaplastic variant of myeloma","volume":"35","author":"Harankhedkar","year":"2018","journal-title":"Turkish Journal of Hematology"},{"key":"10.1016\/j.path.2025.01.004_bib35","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00277-013-1950-7","article-title":"Sustained remission and reversal of end-organ dysfunction in a patient with anaplastic myeloma","author":"Agrawal","year":"2014","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.path.2025.01.004_bib36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ccr3.2425","article-title":"Anaplastic multiple myeloma resembling dysplastic megakaryocytes","volume":"8","author":"Xie","year":"2020","journal-title":"Clin Case Rep"},{"issue":"2","key":"10.1016\/j.path.2025.01.004_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11899-019-00499-8","article-title":"Solitary plasmacytoma: a review of diagnosis and management","volume":"14","author":"Pham","year":"2019","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.path.2025.01.004_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2024.101095","article-title":"Solitary bone plasmacytoma: long-term clinical outcomes in a single center","volume":"50","author":"Gao","year":"2024","journal-title":"Curr Probl Cancer"},{"issue":"11","key":"10.1016\/j.path.2025.01.004_bib39","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1080\/10428194.2019.1605067","article-title":"New insights in the treatment of patients with solitary bone plasmacytoma","volume":"60","author":"Mheidly","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.path.2025.01.004_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid sarcoma: presentation, diagnosis, and treatment","volume":"17","author":"Almond","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.path.2025.01.004_bib41","article-title":"Genetic alterations in myeloid sarcoma among acute myeloid leukemia patients: insights from 37 cohort studies and a meta-analysis","volume":"14","author":"Untaaveesup","year":"2024","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.path.2025.01.004_bib42","doi-asserted-by":"crossref","first-page":"9156","DOI":"10.1002\/cam4.5654","article-title":"RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification","volume":"12","author":"Yang","year":"2023","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.path.2025.01.004_bib43","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/cncr.10399","article-title":"Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature","volume":"94","author":"Yamauchi","year":"2002","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.path.2025.01.004_bib44","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.2021014343","article-title":"International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults","volume":"139","author":"Goyal","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.path.2025.01.004_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pbc.21498","article-title":"Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004","volume":"51","author":"Guyot-Goubin","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.path.2025.01.004_bib46","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jaad.2017.05.059","article-title":"Langerhans cell histiocytosis in children: History, classification, pathobiology, clinical manifestations, and prognosis","volume":"78","author":"Krooks","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.path.2025.01.004_bib47","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/1097-0142(19951215)76:12<2471::AID-CNCR2820761211>3.0.CO;2-Z","article-title":"Langerhans\u2019 cell histiocytosis (histiocytosis X) of bone a clinicopathologic analysis of 263 pediatric and adult cases","volume":"76","author":"Kilpatrick","year":"1995","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.path.2025.01.004_bib48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00256-016-2330-x","article-title":"MRI and clinical features of Langerhans cell histiocytosis (LCH) in the pelvis and extremities: can LCH really look like anything?","volume":"45","author":"Samet","year":"2016","journal-title":"Skeletal Radiol"},{"issue":"2","key":"10.1016\/j.path.2025.01.004_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00247-004-1262-0","article-title":"Langerhans\u2019 cell histiocytosis: Pathology, imaging and treatment of skeletal involvement","volume":"35","author":"Azouz","year":"2005","journal-title":"Pediatr Radiol"},{"issue":"1","key":"10.1016\/j.path.2025.01.004_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2559.2002.01418.x","article-title":"Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases","volume":"41","author":"Pileri","year":"2002","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.path.2025.01.004_bib51","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.5858\/arpa.2015-0199-RA","article-title":"Langerhans cell histiocytosis a clinicopathologic review and molecular pathogenetic update","volume":"139","author":"Harmon","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.path.2025.01.004_bib52","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/PAS.0b013e31815b212b","article-title":"Immunohistochemical expression of langerin in langerhans cell histiocytosis and non-langerhans cell histiocytic disorders","volume":"32","author":"Lau","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2025.01.004_bib53","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hon.2388","article-title":"The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis","volume":"36","author":"Ballester","year":"2018","journal-title":"Hematol Oncol"},{"issue":"10","key":"10.1016\/j.path.2025.01.004_bib54","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000000897","article-title":"Cyclin D1 is expressed in neoplastic cells of langerhans cell histiocytosis but not reactive langerhans cell proliferations","volume":"41","author":"Shanmugam","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2025.01.004_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/jid.1961.80","article-title":"An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo","volume":"37","author":"Birbeck","year":"1961","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.path.2025.01.004_bib56","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.path.2025.01.004_bib57","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups","volume":"211","author":"Berres","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.path.2025.01.004_bib58","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2025.01.004_bib59","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and targetable kinase alterations drive histiocytic neoplasms","volume":"6","author":"Diamond","year":"2016","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.path.2025.01.004_bib60","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41591-019-0653-6","article-title":"Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms","volume":"25","author":"Durham","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.path.2025.01.004_bib61","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ijc.31636","article-title":"A novel fusion gene PLEKHA6-NTRK3 in langerhans cell histiocytosis","volume":"144","author":"Cai","year":"2019","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.path.2025.01.004_bib62","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5435\/JAAOS-22-10-643","article-title":"Diagnosis and management of Langerhans cell histiocytosis","volume":"22","author":"DiCaprio","year":"2014","journal-title":"J Am Acad Orthop Surg"},{"issue":"5","key":"10.1016\/j.path.2025.01.004_bib63","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.1002\/ajh.25055","article-title":"Phenotypes and survival in Erdheim-Chester disease: results from a 165-patient cohort","volume":"93","author":"Cohen-Aubart","year":"2018","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.path.2025.01.004_bib64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/bloodadvances.2016001784","article-title":"The clinical spectrum of Erdheim-Chester disease: an observational cohort study","volume":"1","author":"Estrada-Veras","year":"2017","journal-title":"Blood Adv"},{"issue":"13","key":"10.1016\/j.path.2025.01.004_bib65","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.path.2025.01.004_bib66","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/MPH.0b013e3181b76827","article-title":"Erdheim-chester disease in childhood A challenging diagnosis and treatment","volume":"31","author":"Tran","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.path.2025.01.004_bib67","article-title":"Erdheim-Chester disease","volume":"135","author":"Haroche","year":"2020","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.path.2025.01.004_bib68","article-title":"Rosai\u2013dorfman disease between proliferation and neoplasia","volume":"14","author":"Elbaz","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.path.2025.01.004_bib69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5858\/arpa.2021-0116-RA","article-title":"Rosai-dorfman disease of bone and soft tissue","volume":"146","author":"Garcia","year":"2022","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.path.2025.01.004_bib70","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/PAS.0b013e3181ea50b2","article-title":"Primary rosai-dorfman disease of bone A clinicopathologic study of 15 cases","volume":"34","author":"Demicco","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2025.01.004_bib71","first-page":"19","article-title":"Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity","volume":"7","author":"Foucar","year":"1990","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.path.2025.01.004_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.950114","article-title":"Primary intraosseous Rosai\u2013Dorfman disease: an analysis of clinicopathologic characteristics, molecular genetics, and prognostic features","volume":"12","author":"Weng","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.path.2025.01.004_bib73","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001617","article-title":"Rosai-dorfman disease displays a unique monocyte-macrophage phenotype characterized by expression of OCT2","volume":"45","author":"Ravindran","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2025.01.004_bib74","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMcpc2402486","article-title":"Case 30-2024: a 45-year-old woman with kidney lesions and lytic bone disease","volume":"391","author":"Chen","year":"2024","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.path.2025.01.004_bib75","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/modpathol.2017.55","article-title":"Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease","volume":"30","author":"Garces","year":"2017","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2025.01.004_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000833","article-title":"Mutations in SLC29a3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease","volume":"6","author":"Morgan","year":"2010","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.path.2025.01.004_bib77","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.2021013338","article-title":"ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition","volume":"139","author":"Kemps","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.path.2025.01.004_bib78","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2008-03-147017","article-title":"ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy","volume":"112","author":"Chan","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.path.2025.01.004_bib79","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41379-018-0168-6","article-title":"ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion","volume":"32","author":"Chang","year":"2019","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2025.01.004_bib80","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-023-02649-x","article-title":"Multisystem ALK-positive histiocytosis: a multi-case study and literature review","volume":"18","author":"Liu","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.path.2025.01.004_bib81","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001567","article-title":"ALK-positive histiocytosis of the breast A clinicopathologic study highlighting spindle cell histology","volume":"45","author":"Kashima","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2025.01.004_bib82","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00401-019-02027-7","article-title":"ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system","volume":"138","author":"Lucas","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.path.2025.01.004_bib83","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"Cohen","year":"2014","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.path.2025.01.004_bib84","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/ard.2009.124511","article-title":"Systemic mastocytosis and bone involvement in a cohort of 75 patients","volume":"69","author":"Barete","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"10.1016\/j.path.2025.01.004_bib85","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.path.2025.01.004_bib86","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.iac.2018.04.013","article-title":"Bone disease in mastocytosis","volume":"38","author":"Orsolini","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"issue":"7","key":"10.1016\/j.path.2025.01.004_bib87","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/ajh.26962","article-title":"Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management","volume":"98","author":"Pardanani","year":"2023","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.path.2025.01.004_bib88","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00198-013-2305-x","article-title":"Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis","volume":"24","author":"Seitz","year":"2013","journal-title":"Osteoporosis International"},{"issue":"6","key":"10.1016\/j.path.2025.01.004_bib89","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00223-021-00887-4","article-title":"Osteoporosis caused by systemic mastocytosis: prevalence in a cohort of 8392 patients with osteoporosis","volume":"109","author":"Gehlen","year":"2021","journal-title":"Calcif Tissue Int"},{"issue":"3\u20134","key":"10.1016\/j.path.2025.01.004_bib90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/10428199909145725","article-title":"Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults","volume":"35","author":"Escribano","year":"1999","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.path.2025.01.004_bib91","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/modpathol.2010.224","article-title":"Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis","volume":"24","author":"Sotlar","year":"2011","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.path.2025.01.004_bib92","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/ajh.24426","article-title":"Next-generation sequencing in systemic mastocytosis: derivation of a mutation-augmented clinical prognostic model for survival","volume":"91","author":"Pardanani","year":"2016","journal-title":"Am J Hematol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918125000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918125000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T20:00:59Z","timestamp":1753473659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918125000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1875918125000042"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2025.01.004","relation":{},"ISSN":["1875-9181"],"issn-type":[{"type":"print","value":"1875-9181"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematolymphoid Tumors of Bone","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2025.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}